A Novel ASCT2 Inhibitor, C118P, Blocks Glutamine Transport and Exhibits Antitumour Efficacy in Breast Cancer.
Xiao-Dan LyuYang LiuJia WangYuan-Cheng WeiYi HanXue LiQian ZhangZheng-Rui LiuZheng-Zheng LiJing-Wei JiangHao-Lin HuSheng-Tao YuanLi SunPublished in: Cancers (2023)
C118P exerts an antitumour effect against breast cancer via the glutamine transporter ASCT2.
Keyphrases